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a  b  s  t  r  a  c  t
Gallic  acid  (GA) and  its derivative  methyl  gallate  (MG)  are  well  studied  plant  phenolics.
They  have  exhibited  anticancer  effects  in several  cancer  cell  lines.  However,  the  presence
of  GA/MG  in the seed  coats  of Givotia  rottleriformis  and  their  inhibitory  effect  on  human
epidermoid  carcinoma  (A431)  skin  cancer  cells  were  not  reported.  In  this  study  we  have
isolated  and  chemically  characterized  the  bioactive  compounds  GA  and  MG from  the  bioas-
say guided  methanolic  (MeOH)  seed  coat  extracts  of  G.  rottleriformis.  The  fractions  obtained
from open  silica  column  chromatography  were  subjected  to in  vitro  enzymatic  assays.
Among seven  fractions  we  found  that  only  fractions  5 and  6 showed  signiﬁcant  inhibition
activity  toward  COX-1  with  an  IC50 value  of  28  g/mL  and  9.3  g/mL  and  COX-2  with  an  IC50
value  of 35  g/mL  and  7.0  g/mL  respectively.  However,  we could  not  ﬁnd  5-LOX  enzyme
inhibition  activity.  MG  (10  mg/g  DW)  and  GA (6 mg/g  DW)  were  the major  compounds  of
seed coats.  Cell  viability  was  analyzed  by  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl  tetra-
zolium bromide  (MTT)  assay,  which  showed  that  GA/MG  signiﬁcantly  reduced  the  growth
of A431  cells  with  an  IC50 value  of 25  g/mL  and  53  g/mL  and  11  g/mL  and  43  g/mL  at
24  h  and  48  h,  respectively.  However  the  cytotoxic  effect  of  GA/MG  on HaCaT  normal  skin
keratinocyte  cell  line  was  found  to  be  less.  Western  blot  analysis  has shown  that  GA/MG
treatment  down  regulated  Bcl-2 and up regulated  cleaved  caspase-3  with  respect  to increas-
ing doses.  Our  results  conclude  that  GA  and  MG  have  potential  anticancer  effects  and  can
be used  as  therapeutic  agents  for skin  cancers.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe  CC  B∗ Corresponding author at: Department of Plant Sciences, School of Life
Sciences, University of Hyderabad, Gachibowli, Hyderabad, Telangana 500
046, India.
E-mail addresses: gudipallipadmaja@gmail.com,
gprsl@uohyd.ernet.in (P. Gudipalli).
http://dx.doi.org/10.1016/j.toxrep.2015.03.001
2214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open ac
licenses/by-nc-nd/4.0/).D  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Skin diseases are becoming more common worldwide,
because of increasing environmental pollutants, such as
chemical hazards and radiations. Diverse factors inﬂuence
skin cancers, e.g. solar radiation, UV irradiation. More than
one million new skin cancer cases were reported annu-
ally in USA [1]. Increasing incidence of skin cancers was
reported in AIDS (Acquired immune deﬁciency syndrome)
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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concentrated using Rotavapor (R3, Buchi). The extractFig. 1. Chemical structure of (A) gallic acid and (B) methyl gallate.
atients [2]. The cancer chemoprevention by natural
gents such as phytochemicals, minerals and vitamins
ere shown to have effective results on various malig-
ancies [3,4]. The curcumin isolated from plants inhibits
V-irradiation-induced oxidative stress and enhanced
poptosis in A431 cells [1,5]. The isolated resveratrol from
lants was reported to have potential anti-cancer effect
hat enhanced apoptosis in A431 cells [6].
In this study we used the seed coats of Givotia rottleri-
ormis, a tree species that belongs to Euphorbiaceae family.
his plant grows in limited areas and particularly in the
orests of Andhra Pradesh, Karnataka, Tamil Nadu and West
engal in India. In our previous study we have observed
hat the seeds of this plant were rich in phenolics [7] and
ere reported to have anti-rheumatic, anti-psoriatic and
nti-dandruff medicinal properties [8].
The gallic acid is isolated from plants [9,10] and the
ntioxidant and anticancer effect of GA were well reported
n most of the cancer cells [9,11–17]. Many of GA derived
hemical derivatives were also shown to have good anti-
ancer properties [18]. Methyl gallate, a methyl ester of GA,
as also isolated from several plants [19,20]. The biosyn-
hesis of GA and MG  takes place via dihydroshikimate, a
erivative of phenylpropanoid biosynthesis [21]. The anti-
ancer and anti oxidant effects of MG was reported in
ifferent cancer cells [22–27]. In addition MG  was  also
hown to have anti-bacterial and anti-viral properties
28–30].
Cyclooxygenases (COX-1 and COX-2) and lipoxyge-
ases (5-LOX, 12-LOX, 15-LOXa and 15-LOXb) are the key
nzymes of arachidonic acid (AA) metabolism [31]. Previ-
us reports suggested that inducible form of COX-1 and
OX-2 leads to the biosynthesis of prostaglandins and thus
auses inﬂammation and cancer [32–34]. Inhibition of 5-
OX blocks production of 5-LOX metabolites and triggers
poptosis in prostate cancer cells [35]. Therefore, iden-
iﬁcation of natural dual COX-2/5-LOX inhibitors is an
nteresting area of research to control cancer progression
36].
The over expression of Bcl-2 protein causes reduction
f apoptosis in cancer cells [37–40]. In contrast, the up-
egulation of cleaved caspase-3 activated by other caspases
41,42], enhances apoptosis and thus reduces cancer cell
urvival [43–45].
In the present study, we have isolated GA and MG  from
he seed coats of G. rottleriformis using chromatographic
echniques and chemically characterized them using IR,
MR  and LC–MS analysis (Fig. 1). The inhibitory effect ofeports 2 (2015) 520–529 521
GA or MG  on COX-1, COX-2 and 5-LOX was determined.
We further studied the cytotoxic effect of puriﬁed GA and
MG on human epidermoid carcinoma (A431) skin can-
cer cell line and normal human skin keratinocyte cell line
HaCaT using MTT  assay. The apoptotic effect of GA/MG was
studied by western blotting analysis of Bcl-2 and cleaved
caspase-3 in a dose dependent manner.
2. Materials and methods
2.1. General procedure
IR spectra was  determined in the KBr pellet using
a JASCO FT-IR model 5300 spectrophotometer with
polystyrene as reference. NMR  spectra were recorded at
400 MHz  for 1H NMR  and 100 MHz  for 13C NMR  on Bruker-
Avance-400 spectrometer with chloroform-d as solvent
and tetramethylsilane (TMS) as reference (ı = 0 ppm) in
DMSO-d6 at 25 ◦C. The chemical shift was expressed in ı,
downﬁeld from the signal of internal TMS. Mass spectra
were recorded using LC–MS-2010 (Shimadzu).
2.2. Plant materials
Mature and dry seeds of G. rottleriformis were collected
during summer from Regional Forest Research Centre
(RFRC), Rajahmundry, Andhra Pradesh, India.
2.3. Cell lines and reagents
A431 skin cancer cell line and normal HaCaT skin
cell line were obtained from National Centre for Cell
Science (NCCS), Pune, India. Dulbeco’s modiﬁed Eagle’s
medium (DMEM), fetal bovine serum (FBS), phosphate
buffered saline (PBS), penicillin and streptomycin were
purchased from GIBCO, Ltd. (BRL Life Technologies, Inc.,
Grand Island, NY). MTT  [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide] and dimethyl sulfoxide
(DMSO) were obtained from Sigma; poly-l-lysine, glu-
taraldehyde, proteinase inhibitor K, propidium iodide
(PI), phenyl methyl sulfonyl ﬂuoride (PMSF), luepeptin,
aprotinin, pepstatin A, trypsin, Tween 20, Triton X-100,
TMPD (N,N,N,N′-tetramethyl-p-phenylenediamine) were
purchased from Sigma Chemical Company (St. Louis,
USA). The primary antibodies for Bcl-2 and cleaved
caspase-3 were obtained from Upstate Biotechnology
(Charlottesville, VA, USA). The GA and MG  were puriﬁed
from the seed coats of G. rottleriformis. All other chemicals
and reagents used in the study were obtained either from
Merck or Sigma.
2.4. Extraction and reverse phase HPLC analysis of crude
extract
The seed coats were macerated into ﬁne powder and
were extracted in methanol (MeOH). The crude extract
was ﬁltered using Whatman No.1 ﬁlter paper and waswas further analyzed with RP-HPLC (Shimadzu) using C18
reverse phase column (Shim-pack column with dimensions
250 mm × 4.6 mm,  particle size 5 M),  with ﬂow rate of
cology R522 S. Kamatham et al. / Toxi
6 mL/min and detection at 280 nm.  The mobile phase used
was a complex gradient of solvent-A (water:acetic acid,
1000:1), and solvent-B (MeOH:acetic acid, 1000:1).
2.5. Open silica column and RPHPLC
The crude extract (10 g) was chromatographed using
(Acme’s) silica gel (100–200 mesh). Hexane and ethyl
acetate was used as a mobile phase. Each fraction was
passed through a thin layer chromatography (TLC) using
silica gel plates (Merck 60F254) and visualized by irradia-
tion with UV light and/or by iodine vapors. COX-1, COX-2
and 5-LOX assays were performed for all the fractions (see
below). Only fractions that showed signiﬁcant bioactivity
were resolved using RP-HPLC (method mentioned above),
isolated and concentrated by lyophilizer. The puriﬁed com-
pounds were stored at room temperature and were used for
bioassays and further analysis.
2.6. Isolation of COX-1 enzyme
We  isolated COX-1 enzyme from Ram seminal vesicles
using Hemler and Lands [46] method with slight modiﬁ-
cations. In brief, Ram seminal vesicles were minced and
homogenized in Tris–HCl (pH 8.0) buffer for 1 min; the
homogenate was ﬁltered through cheese cloth and cen-
trifuged at 13,000 × g at 4 ◦C for 30 min. Finally 0.01%
sodium azide was added to the supernatant. It was  stored
as small aliquots at −80 ◦C and was used as COX-1 enzyme
source.
2.7. Isolation of COX-2 enzyme
The enzyme COX-2 was isolated according to the
method of Reddy et al. [47] with slight modiﬁcations. In
brief, human recombinant COX-2 enzyme was expressed
in Sf-9 cells. Cells were pelleted down by centrifugation at
2000 rpm and the cells were further resuspended in 50 mM
Tris–HCl buffer (pH 7.2) and sonicated for 3 min  followed
by centrifugation at 90,000 × g at 4 ◦C for 1 h 20 min  using
ultracentrifuge (Hitachi, Himac CP-100). The obtained
pellet was re-suspended in 2.5 mM Tris–HCl buffer (pH
7.2), 0.8% Tween 20, 1 mM phenol, and 0.5% glycerol. It
was stored as small aliquots at −80 ◦C and used as COX-2
enzyme source.
2.8. COX-1 and COX-2 enzyme activity
We  used the method of Copeland et al. [48] with slight
modiﬁcations to measure the enzymatic activities of both
COX-1 and COX-2, based on the chromogenic assay and oxi-
dation of TMPD during the reduction of prostaglandin G2
(PGG2) to prostaglandin H2 (PGH2). In brief, the assay mix-
ture contained Tris–HCl buffer (100 mM,  pH 8.0), hematin
(15 M),  EDTA (3 M),  enzyme (COX-1 or COX-2) and test
compound. The assay mixture was pre-incubated at 25 ◦C
for 15 min  and the reaction was initiated by addition of AA
and TMPD to a ﬁnal volume of 1 mL.  The activity was mea-
sured by estimating the rate of TMPD oxidation with an
increase in absorbance at 603 nm during 1 min. A low rate of
non-enzymatic TMPD oxidation observed in the absence ofeports 2 (2015) 520–529
COX-1 or COX-2 enzymes was  used as control reaction and
was  subtracted from the test experimental values while
calculating the percent inhibition.
2.9. 5-LOX assay
The 5-LOX enzyme was extracted from potato tubers
and assayed according to Reddanna et al. [49]. The enzyme
activity was  measured using polarographic method with
a Clark’s oxygen electrode on Strathkelvin instruments,
model 782, RC-300. The typical reaction mixture contained
50–100 L of enzyme and 10 L of substrate (133 M of
AA), 100 mM phosphate buffer (pH 6.3) in a total volume of
3 mL.  The rate of decrease in the oxygen concentration was
taken as a measure of enzyme activity. The stock solutions
of the test compounds were freshly prepared before use
and were dissolved in DMSO. Various concentrations of the
test compound were prepared and the 5-LOX was initiated
by the addition of the substrate. The assay was  performed
at 25 ◦C and the maximum slope generated was  taken for
calculating the activity. The percent inhibition was  calcu-
lated by the comparison of 5-LOX activity in the presence
or absence of the inhibitor and IC50 value was calculated
from the concentration–inhibition response curve.
2.10. Cell culture
A431 cells and HaCaT cells were grown as a monolayer
in petriplates and supplemented with DMEM that contains
10% heat inactivated FBS, 100 IU/mL penicillin, 100 g/mL
streptomycin, 2 mM l-glutamine and maintained at 37 ◦C in
a humidiﬁed atmosphere with 5% CO2. The cells were sub-
cultured twice in a week and the exponentially growing
cells were used for the analysis.
2.11. MTT assay
A431 cells and HaCaT cells (5 × 103 cells per well) were
seeded in 96 well plates and were treated with or with-
out GA/MG at various concentrations (0.1, 10, 25, 50 and
100 g/mL) in a ﬁnal volume of 100 L and incubated for
24 h and 48 h. Later 20 L of MTT  (5 mg/mL  in PBS) was
added to each well and incubated for an additional 3 h
at 37 ◦C. The culture medium was removed and 50 L of
DMSO was added to each well to dissolve the purple-blue
formazan crystals and optical density was  measured at
570 nm using ELISA multi mode plate reader (SYNERGYMX,
Bioteck).
2.12. Preparation of whole cell extract and Western blot
analysis
The cells were treated with or without GA or MG  at
various concentrations (25, 50 and 100 g/mL) for 24 h.
Then the cells were washed with PBS and harvested by
trypsinization and ﬁnally cell pellets were resuspended
in RIPA buffer containing 1× protease inhibitor cocktail
followed by incubation for 30 min  at 4 ◦C with frequent vor-
tex. The lysate was  centrifuged at 10,000 rpm for 30 min
and the supernatant was collected as whole-cell extract
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50]. The protein concentration was estimated by Brad-
ord method Bradford [51]. The total protein was resolved
n 12% SDS-PAGE and transferred onto nitrocellulose (NC)
embrane. The NC membrane was then incubated in 5%
w/v) non-fat dry milk powder at room temperature for 1 h
o block non-speciﬁc sites. The NC membrane was incu-
ated with the primary antibody of interest for 12 h at 4 ◦C
nder shaking (cleaved caspase-3, and Bcl-2) and washed
hrice with TBST. The NC membrane was again incubated
ith the respective secondary antibody conjugated with
RP for 1 h at room temperature, and again washed thrice
ith TBST. The blot was developed by adding HRP substrate
PerkinElmer; Western lightning Plus-ECL).
.13. Statistical analyses
The data was presented graphically as the
ean ± standard deviation (SD). Statistical analysis
as done using Sigma Plot 12.0 software and the graphs
ere plotted using Graph pad prism 6.0 software.
. Results
.1. RP-HPLC analysis and column chromatography of
eed coat extract
The crude seed coat extract subjected to RP-HPLC and
he resolved chromatogram showed 10 major peaks at
ifferent retention times (RTs). Peak-1 eluted at 9.0 min,
eak-2 at 25.9 min, peak-3 at 28.6 min, peak-4 at 33.1 min,
eak-5 at 40.8 min, peak-6 at 42.1 min, peak-7 at 44.7 min,
eak-8 at 47.7 min, peak-9 at 50.0 min  and peak-10 at
7.0 min  (Fig. 2). The crude seed coat extract (10 g) was
ractionated into one to seven fractions, fraction 1 (0.6 g),
raction 2 (5.0 g), fraction 3 (1 g), fraction 4 (0.8 g), fraction
 (1.0 g), fraction 6 (1.2 g), fraction 7 (0.4 g) according to the
olarity using open silica chromatography and the purity
f each fraction was monitored with TLC.
.2. COX-1, COX-2 and 5-LOX enzymatic essays
COX-1, COX-2 and 5-LOX activity were estimated for
ractions 1–7. However, only fractions 5 and 6 inhibited
OX-1 with an IC50 value of 7 g/mL and 5.1 g/mL and
OX-2 with an IC50 value of 9 g/mL and 6.44 g/mL
espectively (Fig. 3A–D). None of the fractions showed 5-
OX inhibition activity.
.3. Isolation and chemical characterization of active
ompound from fraction 5
The bioassay guided fraction 5 that showed only a single
eak at RT of 41.5 min, when resolved by RP-HPLC was  col-
ected (Fig. 4A). The isolated compound was subjected to IR,
H, 13C NMR  and LC–MS analysis and identiﬁed as MG  (Sup-
lementary Fig. S1–S4). IR (KBr) cm−1: 3506 (O H), 1697
C O), 1618 (C C), 1541, 1471, 1439, 1313, 1251, 1195,
037, 767, 746 (Supplementary Fig. S1). 1H NMR  (400 MHz,
DCl3) ı ppm: 7.26 (S, 2H, A), 4.01 (S, 2H, B) (Supplemen-
ary Fig. S2). 13C NMR  (200 MHz, CDCl3) ı ppm: 165.67 (C7,eports 2 (2015) 520–529 523
C O) 144.10 (C3, C5), 136.99 (C4), 118.82 (C1) 107.86
(C2, C5) 50.36 (C8) (Supplementary Fig. S3). The molecular
mass of isolated MG was determined as 184 using LC–MS
analysis (Supplementary Fig. S4).
3.4. Isolation and chemical characterization of active
compound from fraction 6
RP-HPLC chromatogram of fraction 6 that showed
a mixture of 3 compounds eluted at different RTs, C1
(600 mg)  at RT 27.49 min, C2 (250 mg)  at RT 40.8 min
and C3 (350 mg)  at RT 51.4 min  were isolated separately
(Fig. 4B). MTT  assay results showed that signiﬁcant inhi-
bition of A431 cell proliferation was seen when treated
with C1, whereas treatment with C2 or C3 did not show
any inhibitory effect on cell proliferation. The active C1
was subjected to IR, 1H, 13C NMR  and LC–MS analysis and
its chemical structure was identiﬁed as GA. IR (KBr) cm−1
33.71 ( COOH), 3057 (C H), 1705 ( C O), 1620 (C C),
1452, 1338, 1248, 1026, 702 (Supplementary Fig. S5). 1H
NMR  ı ppm: 12.52 (S, H acid OH), 7.22 (S, 2H) (Supplemen-
tary Fig. S6). 13C NMR  ı ppm: 167.01 (C7 C O), 143.98 (C3,
C5), 136.61 (C4), 119.87 (C1) 108.14 (C2, C6); (Supplemen-
tary Fig. S7). The mass of the puriﬁed GA was determined
as 169 by LC–MS (Supplementary Fig. S8).
3.5. MTT assay
Dose and time dependent effect of GA and MG on A431
and HaCaT cell proliferation was investigated. A431 cells
that were treated with various concentrations of GA/MG
(1, 10, 25, 50 and 100 g/mL) showed signiﬁcantly reduced
cell proliferation due to enhanced cell death (Fig. 5A and B).
GA treatment enhanced A431 cell death in a dose depend-
ent manner with calculated IC50 value of 25 g/mL at 24 h.
The cell death was increased further when the GA treat-
ment time increased to 48 h with an IC50 value of 11 g/mL
(Fig. 5Ai–iv). Similarly MG treatment also reduced A431 cell
proliferation in a dose dependent manner. MG  treatment
showed reduced A431 cell proliferation with an IC50 value
of 53 g/mL at 24 h. However when the MG treatment time
increased to 48 h the rate of cell death also increased fur-
ther with an IC50 value of 43 g/mL (Fig. 5Bi–iv). HaCaT
cells that were treated with same GA concentrations (1, 10,
25, and 100 g/mL) showed low level of reduction in cell
proliferation with the calculated IC50 values of 84.2 g/mL
at 24 h and 64.4 g/mL at 48 h, respectively (Fig. 6Ai–iv).
MG treatment also showed reduced effect on HaCaT cell
proliferation with an IC50 value of 79.4 g/mL at 48 h
(Fig. 6Bi–iv).
3.6. Western blot analysis
Treatment of A431 cells with GA and MG down regu-
lated Bcl-2 and thus enhanced apoptosis in dose (25, 50cleaved caspase-3 was also induced in a dose dependent
manner with increasing doses of GA and MG  treatment
(Figs. 7Aii and 6Bii). -Actin was  used as a loading control
(Fig. 7Aiii and Biii).
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Fig. 2. High-performance liquid chromatography (HPLC) analysis of crude extract of G. rottleriformis seed coats using a reverse phase C18 column. High-
performance liquid chromatography (HPLC) chromatogram showing crude compounds resolved at their respective retention times (RTs).
Fig. 3. COX-1 and COX-2 inhibition activity of fractions 5 and 6. (A) COX-1 inhibition of fraction 5, (B) COX-2 inhibition of fraction 5, (C) COX-1 inhibition
of  fraction 6 and (D) COX-2 inhibition of fraction 6.
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. Discussion
Plants synthesize a wide range of metabolites for their
urvival, growth, development and protection from a broad
pectrum of bacterial, fungal and viral pathogens. Some
f the plant metabolites work as anti-oxidant and anti-
ancer drugs because of their toxic effect toward cancer
ells [6,26,52]. In this study we isolated GA and MG  as
ajor metabolites from the seed coats of G. rottleriformis.
he total seed coat extract was fractionated and subjected
o COX-1/COX-2/5-LOX assays and cytotoxic efﬁciency was
onducted on A431 cells and HaCaT cells. The HPLC chro-
atogram data of MeOH seed coat extract revealed a group
f peaks that were fractionated from one to seven by open
ilica column chromatography. Among all the fractions,
nly 5 and 6 fractions signiﬁcantly inhibited COX-1 and
OX-2 enzyme activity (Fig. 3a–d). However, these frac-
ions did not show any signiﬁcant inhibition on 5-LOX
nzyme activity. Earlier studies have demonstrated that
OXs and LOXs are the key enzymes that play an impor-
ant role in inﬂammation and carcinogenesis [10,11,52].
nly 5 and 6 chromatographed fractions that inhibitedm fraction 6 by high-performance liquid chromatography (HPLC) using a
the A431 cell proliferation was further subjected to active
compound isolation by RP-HPLC. The active compounds
of fractions 5 and 6 were puriﬁed by RP-HPLC (Fig. 4A
and B) and were identiﬁed as GA and MG using IR, NMR
and LC–MS analysis. GA and MG  are natural constituents
isolated from different plants [19,25,29]. Phenylpropanoid
metabolism produce enormous array of secondary metabo-
lites. The biosynthesis of GA and its derivative MG  takes
place via phenylpropanoid metabolism [21]. Our results
suggest that MG  (10 mg/g DW)  and GA (6 mg/g DW)  are
the major compounds of the seed coats of this plant. We
have also isolated several phenylpropanoid metabolites
both known and unknown and studied their role in induc-
ing plant immunity (Samuel et al., unpublished data). It
was well demonstrated that some plant compounds such as
curcumin, resveratrol and -santalol suppressed cell pro-
liferation and enhanced apoptosis in A431 cells [1,5,6].
Treatment of A431 cells with GA/MG suppressed cell
survival by enhanced apoptosis in a dose and time depend-
ent manner (Fig. 5Ai–iv and Bi–iv). The cytotoxic effect
of GA and MG  was investigated in various cancer cells
[11,26,53–55]. The GA isolated from Terminalia bellerica
526 S. Kamatham et al. / Toxicology Reports 2 (2015) 520–529
Fig. 5. Gallic acid (GA) and methyl gallate (MG) reduced the cell viability of A431 cells. Cells were seeded at a density of 1 × 106 cells/mL in 96 well polystyrene
culture plates and maintained at 37 ◦C with 5% (v/v) CO2 for 1 day. After 24 h the cells were incubated with GA/MG at the indicated concentrations for 24 h
and  48 h and then processed for MTT  assay. (Ai–iv) Percentage of cell death and viability of A431 cells treated with GA in a dose dependent manner at 24 h
and  48 h. (Bi–iv) Percentage of cell death and viability of A431 cells after treatment with MG at 24 h and 48 h. The data presented as the mean ± SD of three
independent experiments. The bars represent statistical signiﬁcance over control (P < 0.05).
Fig. 6. Gallic acid (GA) and methyl gallate (MG) reduced the cell viability of HaCaT normal skin keratinocyte cell line. Cells were seeded at a density of
1  × 106 cells/mL in 96 well polystyrene culture plates at 37 ◦C with 5% (v/v) CO2 for 1 day. After 24 h the cells were incubated with GA/MG at the indicated
) Percen
 and via
nt expeconcentrations for 24 h and 48 h and then processed for MTT assay. (Ai–iv
dose  dependent manner at 24 h and 48 h. (Bi-iv) Percentage of cell death
at  24 h and 48 h. The data presented as the mean ± SD of three independe
potentially inhibited COX-1 and COX-2 enzymes in a con-
centration dependent manner [10]. Similarly, MG also
showed dual COX-2/5-LOX inhibitory activity; however, 5-
LOX inhibition was based on the leukotriene C4 [36]. Similar
results were observed with our data with GA inhibiting
both COX-1 and COX-2 enzymes in a dose dependent man-
ner [10]. The inhibition of COX-2 enzyme by MG was similar
as that mentioned by Kim et al. [36]. The COX-1 activity of
fraction 5 and the puriﬁed MG  were the same (IC50 valuetage of cell death and viability in HaCaT cells when treated with GA in a
bility in HaCaT cells when treated with MG  in a dose dependent manner
riments. Bars represent statistical signiﬁcance over control (P < 0.05).
of 28 g/mL). Here we  report for the ﬁrst time the COX-1
inhibition activity of MG.  We  have not observed any effect
of GA on 5-LOX activity and our results were consistent
with the ﬁndings from previous reports [10]. Whereas the
5-LOX activity of MG  could not be observed even at increas-
ing concentrations though it was  earlier reported that MG
exhibits 5-LOX inhibition activity [36].
The anti-oxidant and anti-proliferative effects of GA/MG
were well studied [11,19,20,22,26,28,30,53]. In our results,
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Fig. 7. Western blotting analysis showing Bcl-2 and cleaved caspase-3 protein up regulation in A431 cells that were treated with puriﬁed gallic acid
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ells. (Bii) Up regulation of the expression of cleaved caspase-3 with incre
he treatment of A431 cells with puriﬁed GA suppressed
he growth of A431 cells in a dose dependent manner with
n IC50 value of 25 g/mL and 11 g/mL at 24 h and 48 h,
espectively (Fig. 5Ai–iv). On the other hand, GA has shown
uch less cytotoxic effect on HaCaT normal skin kerati-
ocyte cell line and showed IC50 value of 84.2 g/mL and
2.4 g/mL at 24 h and 48 h, respectively (Fig. 6Ai–iv). The
nti-proliferative and apoptotic properties of phytochemi-
als were demonstrated in A431 cells [1,5,6]. However this
s the ﬁrst observation that reported the effect of GA on
431 cells. Similarly MG  reduced the cell proliferation with
n IC50 value of 53 g/mL and 48 g/mL at 24 h and 48 h
espectively (Fig. 5Bi–iv). In the same way, normal skin
aCaT cells that were treated with MG showed less cyto-
oxicity with an IC50 value of 79.4 g/mL than A431 cancer
ells (Fig. 6Bi–iv). It was suggested by previous reports that
G inhibits cancer cells [25,53]. Our data showed that the
reatment of A431 cells with GA and MG down regulated
cl-2 (Fig. 7Ai and Bi). Bcl-2 promotes cell proliferation
nd reduced apoptosis in cancer cells [56–59]. Treatment
f A431 cells with GA or MG  also upregulated the protein
evels of cleaved caspase-3 in a dose dependent manner
Fig. 7Aii and Bii). Caspase-3 was reported as an apoptotic
arker protein, the expression of which enhances apopto-
is, cleaves key cellular proteins and promotes cell death in
ancer cells [56,60–62]. Apart from cancer, because of anti-
xidant property of GA, GA and its ester derivatives were
idely used as additives in food industry [63]. In summary,
his study demonstrates that the seeds coats of G. rottleri-
ormis are a rich source of GA/MG and may  play signiﬁcant
ole in treatment of various cancers. These results demon-
trate and encourage the need of further studies to establish
he role of GA or MG as potential anti-inﬂammatory drugs
o avoid the risk of various skin and other cancer problems.
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